A mouse homolog of P-selectin glycoprotein ligand-1 (PSGL-1). a P-selectin receptor on myeloid cells, has been cloned using the human cDNA sequence to probe a cDNA library prepared from the mouse WEHI-3 monocytic cell line and a genomic DNA library prepared from 129lSvJ mouse tissue. The gene flanking the entire open reading frame of 397 amino acids is composed of a single exon. Mouse and human PSGL-1 show an overall similarity of 67% and an identity of SOYO and contain a similar domain organization. However, there are 10 threoninehrine-rich decameric repeats in mouse PSGL-1 as compared with 15 threonine-rich repeats in human PSGL-1. When the mouse PSGL-1 cDNA is coexpressed with an (~1,311.4 fucosyltransferase cDNA in COS cells, a functional protein is expressed on the COS cell surface mediating binding to human P-selectin. The mouse PSGL-1 gene, Selpl, was mapped to a position on mouse chromosome 5 (Chr 5). Northern blot analyses of mouse tissues showed moderate expression of a PSGL-1 mRNA HE SELECTIN FAMILY of adhesion molecules is cru-T cial for the initial interaction of circulating leukocytes with the vascular endothelium at the site of injury.'-4 The three members of the selectin family include P-selectin, Lselectin, and E-selectin. L-selectin is expressed on a subset of lymphocytes and leukocytes. P-selectin and E-selectin are expressed on activated endothelial cells. In addition, Pselectin is expressed on activated platelets. All selectin molecules contain an N-terminal domain homologous to Ca++-dependent lectins5 that recognize carbohydrate determinants related to sialyl Lewis" and sialyl Lewis" structure^.^^^-^ Binding of selectins to leukocytes or endothelium is mediated through a restricted number of glycoprotein ligands. Three mucin-like molecules including GlyCAh4-1 ,lo CD34," and MAdCAM-1 l2 have been identified as L-selectin ligands of potential physiological significance. Similar to other mucinlike molecules, these L-selectin ligands contain long repetitive sequences rich in serine and threonine that provide attachment sites for extensive 0-glycosylation. Oligosaccharide modifications of sialylation, sulfation, and, probably, fucosylation are required for L-selectin binding.l3-I6 Al- The nucleotide sequence reported in this article has been submitted to the GenBanWEMBL Data Bank with accession number X91144.
PSGL-1 show an overall similarity of 67% and an identity of SOYO and contain a similar domain organization. However, there are 10 threoninehrine-rich decameric repeats in mouse PSGL-1 as compared with 15 threonine-rich repeats in human PSGL-1. When the mouse PSGL-1 cDNA is coexpressed with an (~1,311.4 fucosyltransferase cDNA in COS cells, a functional protein is expressed on the COS cell surface mediating binding to human P-selectin. The mouse PSGL-1 gene, Selpl, was mapped to a position on mouse chromosome 5 (Chr 5). Northern blot analyses of mouse tissues showed moderate expression of a PSGL-1 mRNA
HE SELECTIN FAMILY of adhesion molecules is cru-
T cial for the initial interaction of circulating leukocytes with the vascular endothelium at the site of injury.'-4 The three members of the selectin family include P-selectin, Lselectin, and E-selectin. L-selectin is expressed on a subset of lymphocytes and leukocytes. P-selectin and E-selectin are expressed on activated endothelial cells. In addition, Pselectin is expressed on activated platelets. All selectin molecules contain an N-terminal domain homologous to Ca++-dependent lectins5 that recognize carbohydrate determinants related to sialyl Lewis" and sialyl Lewis" structure^.^^^-^ Binding of selectins to leukocytes or endothelium is mediated through a restricted number of glycoprotein ligands. Three mucin-like molecules including GlyCAh4-1 ,lo CD34," and MAdCAM-1 l2 have been identified as L-selectin ligands of potential physiological significance. Similar to other mucinlike molecules, these L-selectin ligands contain long repetitive sequences rich in serine and threonine that provide attachment sites for extensive 0-glycosylation. Oligosaccharide modifications of sialylation, sulfation, and, probably, fucosylation are required for L-selectin binding.l3-I6 Al- The nucleotide sequence reported in this article has been submitted to the GenBanWEMBL Data Bank with accession number X91144.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.
0 1996 by The American Society of Hematology. .00/0 species in most tissues including heart, kidney, liver, muscle, ovary, and stomach and high lev& of expression in blood, bone marrow, brain, adipose tissue, spleen, and thymus. Whereas certain mouse myeloid cell lines including PU5-1.8, WEHIIB, and 32DC13 express high levels of PSGL-1 mRNA, only WEHI-38 and 32DC13 bind to P-selectin; this interaction is blocked by anti-PSGL-1 antibody. WEHI-3B cells bind s i g nificantly better t o P-selectin than to E-selectin. Although comparable P-selectin binding is observed in 32DC13 cells, these cells bind better to E-selectin. Binding of 32DC13 cells to E-selectin is not blocked by anti-PSGL-1 antibody. Treatment of WEHIJB cells with trypsin or neuraminidase abolished their ability to interact with P-selectin. These results indicate that mouse PSGL-1 has structural and functional homology to human PSGL-1 but is characterized by differences in the composition and number of the decameric repeats. PSGL-1 on mouse myeloid cells is critical for highaffinity binding to P-selectin but not to E-selectin. 0 1996 by The American Society of Hematology.
though sialyl Lewis" itself provides stable interaction with E-selectin, a 150-kD glycoprotein that binds to E-selectin has been identified."." The cDNA sequence of this protein, E-selectin ligand-1 (ESL-l), shows strong homology to the chicken fibroblast growth factor receptor." The P-selectin glycoprotein ligand-1 (PSGL-l), another mucin-like molecule, was identified in human neutrophils and HL-60 cells.20-22 The cDNA for this protein derived from HL-60 cells has been coexpressed with a cDNA encoding an a1,3/1,4 fucosyltransferase (lT-III).23 PSGL-1 shows a large amount of sialylated, fucosylated 0-linked carbohydrate~,"~'~ and it was shown to mediate in vitro rolling of neutrophils on P-~electin.'~ The human PSGL-1 purified from neutrophils and the recombinant protein expressed from the COS cells binds to E-~electin."-~~ A distinct function of PSGL-1 for P-selectin binding has been suggested in an in vitro T-lymphocyte rolling assay.26 Polyconal antibodies against PSGL-1 interfered with rolling of T lymphocytes on P-selectin but showed no effect on the attachment of T cells to E-selectin.
To determine the physiological role of PSGL-1 in vivo and to learn if PSGL-1 is the biologically important P-selectin ligand on myeloid cells, we have begun to investigate the biology of PSGL-1 in the mouse. In this study, we have cloned the cDNA and the gene encoding the mouse homolog of PSGL-1, determined the chromosomal location of the mouse PSGL-1 gene and the tissue distribution of PSGL-1 mRNA, and characterized the functional properties of PSGL-1 expressed on myeloid and heterologous cells. Mouse PSGL-1 shares structural and functional homology with the human PSGL-1, but is also characterized by significant differences.
(6,000 Ci/mmol) were from Dupont-New England Nuclear (Boston, MA). The deoxyribonucleotide triphosphate was from Pharmacia (Uppsala, Sweden). Synthetic oligonucleotides were prepared on an Applied Biosystems DNA Synthesizer (Applied Biosystems, Foster City, CA). WEHI-3 cells and PU-5 cells were obtained from American Tissue Culture Collection (ATCC; Rockville, MD). WEHI-3B cells and 32DC13 cells were a gift from Dr G. Rovera (Wistar Institute, Philadelphia, PA). The plasmids expressing (~1,3/1,4 fucosyltransferase (pEARIII) and human PSGL-1 were a gift from Dr D. Sako (Genetics Institute, Cambridge, MA). The CD43 expressing plasmid, pCDM8CD43, was a gift from Dr B. Ardman (New England Medical Center, Boston, MA). Rabbit polyclonal antisera against a peptide derived from the first 19 residues after the putative propeptide cleavage site of mouse PSGL-1 ( Fig 1A) and against the soluble protein of human PSGL-l*' were gifts from Genetics Institute. Rabbit antihuman P-selectin antibodies (SA-l) were raised in this laboratory against the purified protein.
DNA fragments were labeled with [3zP]cr-deoxycytidine triphosphate to a specific activity of greater than lo9 c p d p g DNA by the random oligonucleotide primer method.27 Buffer and free nucleotides were removed by passing through a Push Column (Stratagene, La Jolla, CA). Approximately 1.5 X lo6 plaques from an adult 129/SvJ mouse liver genomic DNA library cloned into 1 FIX I1 (W46305; Stratagene) was screened using a probe derived from a 1.6-kb insert of the full length human PSGL-1 cDNA (Genetics Institute). Hybridization was performed at 65°C overnight in a sodium chloride, sodium phosphate, and EDTA (SSPE) hybridization buffer containing 5X SSPE, 0.15% sodium dodecyl sulfate (SDS), and 10 pg/mL salmon sperm DNA. The filters were washed in 1 x sodium chloride and sodium citrate (SSC) containing 0.2% SDS at room temperature for 30 minutes. Phage DNA samples from five positive clones were isolated and analyzed by restriction digestion followed by Southern blot hybridization using the full length probe and a probe derived from the cytoplasmic tail. Restriction fragments of interests were subcloned into the pBluescript I1 vector (Stratagene).
A mouse macrophage (WEHI-3) cDNA library in the Uni-ZAP vector (W37306; Stratagene) was screened. The probe was prepared by polymerase chain reaction (PCR) amplification of the cytoplasmic tail of PSGL-I using the human PSGL-1 cDNA or the mouse genomic DNA clones and primer pairs W (5'AAGGG CCAGA TGTAC CCCGT (33') and P8 (5'CTAAG GGAGG AAGCT GTGCA G3') derived from the human cDNA sequence. The filters were finally washed with 0.2X SSC containing 0.2% SDS at 45°C for 15 minutes. Positive clones were present in a frequency of about 1 in every 5 X IO4 plaques. Positive clones were purified and subjected to in vitro excision. Plasmid DNA from five of these clones was further purified and analyzed by restriction digestion and sequencing. A cDNA artifact was found in two of these clones because they contained a chimeric molecule containing a 5' sequence of an unknown species.
Sequencing of plasmid DNA was performed using the Sequenase Version 2.0 kit from US Biochemicals. Overlapping sequences were obtained by using oligonucleotide primers from both strands or from more than one independent primer in the same orientation. The final sequence was assembled and analyzed using the programs of the Genetics Computer Group (Madison, WI).
Poly(A)+ RNA was prepared from WEHi-3 cells using the FastTrack mRNA isolation method (Invitrogen, San Diego, CA). The RT reaction was performed using 1 pg of random hexamers and poly(A)+ RNA using the cDNA Cycle kit from Invitrogen. Subsequent PCRs were performed in standard buffer (Boehringer Mannheim) containing 1.75 mmol/L MgC12. About 5% of the first-strand cDNA products were Radioisotope labeling of DNA.
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amplified using 50 pmol of primer P1 and P3 (Fig 1A) in the presence of 0.1 mmol/L of each deoxyribonucleotide triphosphate and 2.5 U Taq DNA polymerase (Boehringer Mannheim). The reactions were subjected to 25 cycles of denaturing at 94°C for 1 minute, annealing at 63°C for 0.5 minutes, and extension at 72°C for 1 minute.
The P1:P3
PCR fragment obtained by RT-PCR was purified from agarose gel using the QIAEX Gel Extraction kit (Qiagen, Chatsworth, CA) and was subcloned into the pCR I1 vector using the TA Cloning kit from Invitrogen. The PCR product was sequenced using synthetic oligonucleotides. An approximately 0.8-kb BamHYAcc I insert containing the complete 5' PSGL-1 sequence was isolated and recombined into the BamHYAcc I sites of a 1.3-kb partial cDNA clone.
The vector was linearized with Xho I and blunt-ended using T4 DNA polymerase. The full length cDNA insert was released by digestion with Xba I, purified from agarose gel and cloned into the Xba YSma I sites of the PED expression vector (Genetics Institute). Mouse lung genomic DNA (10 to 15 pg) from C57BL/6J mice was extracted using SDS and proteinase K,27 was exhaustively digested with restriction enzymes, and was electrophoresed in a 0.8% agarose gel. The gel was transferred to Duralon-UV membrane (Stratagene), bonded in a Stratalinker (Stratagene), and hybridized in the SSPE hybridization buffer as described above. The probe derived from the repeat region of the mouse PSGL-1 cDNA was PCR-amplified using the longest partial cDNA clone and primer T3 (5'TAACC CTCAC TAAAG GGA3') generated from the vector and primer P2 generated from the cDNA insert (Fig 1A) . The probe derived from the cytoplasmic tail of PSGL-1 was obtained as previously described.
Genetic mapping. The progeny of two sets of genetic crosses were typed for inheritance of the mouse PSGL-1 gene: (NFSDJ or C58/J X Mus musculus musculus) X M m musculus" and (NFSDJ X Mus spretus) X M spretus or C58/J.29 The progeny of these crosses have been typed for over 850 markers including the chromosome 5 (Chr 5) markers Pdeb (phosphodiesterase beta), Mea2 (male enhanced antigen 2), and Tcfl (hepatic transcription factor 1) as described previou~ly.~~" Data were stored and analyzed using the program LOCUS developed by C.E. Buckler (National Institutes of Allergy and Infectious Diseases, Bethesda, MD). Recombinational distances were calculated according to Green.32 Total RNA samples (10 to 20 fig) prepared from mouse myeloid cells, WW6 embryonic stem cells (a gift from Dr P. Stanley, Albert Einstein College of Medicine, Bronx, NY) and adult tissues from C57B1/6J mice using Trizol reagent (GIBCO-BRL) were loaded onto a 1.2% to 1.5% agarose-formaldehyde After electrophoresis in 1 X 3-[N-morpholino]propanesulphonic acid buffer, the RNA was transferred to Biotran membrane (ICN Biomedicals, Plainview, NY) in 20X SSC and was bonded in a Stratalinker (Stratagene). Prehybridization or hybridization was performed at 65°C overnight in a PIPES hybridization buffer containing 50 mmol/L piperazine-N,N'-bis(2-ethanesulfonic acid), pH 6.5; 100 mmol/L NaCl; 50 mmol/L sodium phosphate, pH 7.0; 1 mmol/L EDTA; 5% SDS; and 60 pglmL salmon sperm DNA. The probe was a 1.7-kb full length cDNA of mouse PSGL-1.
COS cells, WEHI-3B cells, and PU5-1.8 cells were grown as monolayers in complete Dulbecco's modified Eagle's medium (DMEM; GIBCO-BRL) containing 10% fetal calf serum (GIBCO-BRL). 32DC13 cells were grown in suspension in the same medium supplemented with 10% conditioned medium from confluent WEHI-3B cells. HL-60 cells, Chinese hamster ovary (CHO) cells, P-selectin-expressing CHO cells (CHO-P), and Eselectin-expressing CHO cells (CHO-E) were maintained as described p r e v i~u s l y .~~ CHO, CHO-P, or CHO-E cells were seeded at 1 x 10 cells/ well in 96-well U-bottom plates (Costar, Cambridge, MA) and were
Construction of a m u s e PSGL-1 expression vector.
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CMTWCATATTATAAT-CG-1661 L P R l Q incubated at 37°C and 5% COz for 24 hours to 90% confluency. Before the cell adhesion assay, wells were blocked with Dulbecco's modified Eagle's medium and I % bovine serum albumin for 4 to 6 hours at 37°C and 5% CO?. COS or mouse myeloid cells were harvested. resuspended at I x 10" cellslmL of 5 mmolL. EDTA/ phosphate-buffered saline (PBS), and fluorescently labeled with 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescin acetoxymethyl ester (Molecular Probes. Eugene, OR) at a tinal concentration of 0.003-5Q (wUvol) at 37°C and 5% C 0 2 for 30 minutes. Cells were washed and resuspended in Tris-buffered saline (TBS: Tris 10 mmoll L [pH 7.451. 130 mmol/L NaCI, 1 rnmollL CaC12, and 1 mmol/L MgCI:). and I to 2 X IOd labeled cells were added per well and incubated at room temperature for 15 minutes. The fluorescence signal was measured using a Cytofluor 2300 fluorescence measurement system (Millipore Corp. Bedford. MA) set at 485 nm (excitation) and 530 nm (emission) both before and after rinsing wells 3 to 5 times with TBS. The percentage of initial signal was expressed as percentage of cell binding. Each data point represents the results from cight rcplicates and the average from 6 samples (excluding the highcst and the lowest).
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For assays using transfected cells. COS cells were transfected with the plasmids pEDlmPSGL-I, pEAITIII. andor pCDMXCD43 (total, I pg) using Lipofectarnine (GIBCO-BRL) as per the manufacturer's recommended protocol. Cells were harvested for binding assay 48 hours posttransfection by a 10-minute incubation with 5 mniollL EDTAIPRS.
For antibody inhibition analyses, fluorescently labeled WEHI-3B
or 32DC13 cells were washed in TBS and resuspended at 4 X IO' cellslmL in 1:10 dilution of rabbit polyclonal antisera in TBS. The mixture was incubated for 30 minutes at room temperature and was added directly to plates coated with CHO-P or CHO-E cells.
To prepare trypsin-treated cells. fluorescently labeled WEHI-3B cells were resuspended at I X IO"cells/mL in TBS containing bovine trypsin ( I pglmL; Sigma. SI Louis, MO) and were incubated for 60 minutes. To prepare neuraminidase-treated cells. fluorescently labeled WEHI-3B cells were resuspended at I X 10" cellslmL in 5 mmollL EDTAlPBS containing neuraminidase from Vihrio choleroe (200 mUlmL, type II; Sigma) and incubated for YO minutes. Cells were washed 2 to 3 times with TBS before the binding assay. kb contained a partial open reading frame starting at residue 120. The cDNA sequence included a complete 3' untranslated region, having two consecutive AATAAA poly(A) addition sites followed by a poly(A) tail (Fig IA) . The 3' untranslated region is likely to be included in the coding exon as evidenced by partial sequencing of the 4-kb EcoRI genomic DNA fragment using primers P4, P5, and P6 ( Fig  IA) . This is also supported by PCR analysis of the four genomic DNA clones using primers P4 and P6 (data not shown).
RESULTS
Isolation
To obtain a full length cDNA sequence, the 5' region of the mouse PSGL-1 cDNA was obtained from WEHI-3 poly(A)' RNA by RT-PCR. Primer pairs PI and P3 ( Fig  IA) derived from the genomic DNA sequence were used. Sequence analysis of the PCR product showed complete agreement with the corresponding genomic DNA sequence (Fig IA) . The full length cDNA encoding mouse PSGL-I predicts a protein of 397 amino acids. The N-terminus of the protein contains 18 residues of a hydrophobic signal sequence followed by a putative propeptide sequence of 23 residues. A cleavage site (RERR) for the paired basic amino acid-converting enzyme (furin/PACE)'J defines the end of the propeptide region. The sequence of the putative mature protein suggests the following structural features: a large extracellular domain of 265 residues, a transmembrane domain of 24 residues of hydrophobic core, and a cytoplasmic tail of 67 residues. A single extracellular cysteine resides at the N-terminus of the transmembrane domain. In the extracellular region, there are IO decameric repeats and two po- ..,-.........
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S V K -C - This repeat region is rich in serine, threonine, and proline (Fig lB) , characteristic of mucin-like domains.35 In addition, residues 232-306 are rich in serine, threonine, and proline, although the striking repeat pattern of the decameric repeats is not observed. Of the 74 amino acids in this region, 23 are either serine or threonine, and 8 are proline. This would suggest the possibility of important 0-linked glycosylation sites on a peptide backbone that is conformationally constrained by proline residues. Sequence comparison between mouse and human PSGL-I . The mouse PSGL-1 polypeptide is five residues shorter than its human counterpart. The mouse and human PSGL-1 proteins show an overall similarity of 67% and an identity of 50% (Fig 2) . Similar domain structures, including a signal peptide, a propeptide, the decameric repeat units, a transmembrane domain, and a cytoplasmic tail, are present in both species (Fig 2) . The highest degree of similarity is present in the transmembrane domain (91% similarity and 83% identity) and the cytoplasmic tail (86% similarity and 76% identity). The mucin-like repeat regions of mouse and human PSGL-1 contain a similar number of serine/threonine and proline residues but are less conserved at the primary sequence level (Fig 1B) . There are 10 decameric repeats, characterized by a consensus sequence of E-T-S-Q(K)-P-A-P-T(M)-E-A, in mouse PSGL-1. There are 15 decameric repeats, characterized by a consensus sequence of Q-T-T- 
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PSGL-1 and human PSOL-1 were aligned using the
~S R K G H M Y P V R N Y S P T E M V C I S S L L P D G G E G P S A T A N G L 382 B M i program from the G e n h Computer Group
P(A,Q,E,R)-P(L)-A(T)-A-T(M)-E-A, in human PSGL-1 .23
Among the three potential N-glycosylation sites in human PSGL-1 and the two N-glycosylation sites in mouse PSGL-1, only a single site, asparagine 66 of mouse PSGL-1, is common to both.
To determine whether there are other sequences homologous to PSGL-1 present in the mouse genome, Southern blot analysis was performed using a probe derived from the repeat region and a probe derived from the cytoplasmic tail of the mouse PSGL-1 cDNA. As shown in Fig 3, a single band was detected in mouse lung genomic DNA digested with BamHI, EcoRI, and HindIII. Similar results were obtained using restriction enzymes Sac I and Xba I (data not shown). Because BamHI, HindIII, Sac I, and Xba I do not cut within the cDNA of PSGL-1 and because EcoRI only cuts a single site after the repeat region of PSGL-1, a single band detected by the two probes would indicate that the mouse genome contains no other sequences closely related to the PSGL-1 gene or to the domains of the repeat region or the cytoplasmic tail.
Chromosomal localization of mouse PSGL-1 gene, Selpl. Digestion with HindIII produced fragments of 5 kb in NFS/ N and C58/J and of 8.6 kb in M m musculus and M spretus using the full length cDNA of PSGL-1 as a hybridization probe. Inheritance of the variant fragments was followed in both crosses and compared with inheritance of over 850 markers previously typed in these mice. As shown in Fig 4, 
Southem blot analysis.
For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From with PSGL-1 alone had no effect. The results show that mouse PSGL-1 is a functional receptor for human P-selectin.
Expression of PSGL-1 mRNA in mouse myeloid cell lines and in mouse tissues was analyzed by Northern blot experiments using the full length cDNA of mouse PSGL-I as a probe. As indicated in Fig 6A, a major mRNA species of -1 .8 kb and a minor species of -3.4 kb were expressed in 32DC13 neutrophil progenitor cells, PU5-1.8 monocyte-macrophage cells, and WEHI-3B myelomonocytic cells. However, both mRNA species were expressed at a low level in WW6 embryonic stem cells. The signal from the -1.8-kb mRNA was not caused by nonspecific hybridization of the 18s ribosomal RNA because no significant background was detected under the same condition when probes unrelated to PSGL-1 were used. The presence of PSGL-1 mRNA in mouse tissues were also tested. The =1.8-kb species of PSGL-I mRNA was expressed in most tissues including blood, bone marrow, brain, adipose tissue, heart, kidney, liver, muscle, ovary, spleen, and thymus (Fig 6B) . High levels of mRNA expression were found not only in hematopoietic cells derived from blood, bone marrow, spleen, and thymus, but also in nonhematopoietic tissues including brain and adipose tissue (Fig 6B) . For Binding properties qf mouse myeloid cells to human Pselectin and E-selectin. The abilities of PSGL-I -expressing cells, including WEHI3B, 32DC13, and PU5-1.8, to recognize human P-selectin and E-selectin were determined using a cell-binding assay. WEHI-3B and 32DC13 cells bound to both P-selectin and E-selectin bearing CHO cells (CHO-P and CHO-E), in parallel to HL60 cells. However, PU5-1.8 cells did not bind to either CHO-P or CHO-E cells ( Fig 7A) . As shown above, all these myeloid cells synthesize PSGL-I mRNA. Therefore, the failure of PU5-1.8 cells to bind P-selectin probably reflects defects in the posttranslational modification of PSGL-I in the cells. WEHI-3B cells showed a significant preference for CHO-P over CHO-E, but 32DC13 cells and HL-60 cells showed a preference for CHO-E over CHO-P (Fig 7A) . The interaction of 32DC13 cells (Fig 78) or WEHI-3B cells (data not shown) with CHO-P cells was inhibited by polyclonal anti-P-selectin antibodies and by polyclonal anti-PSGL-I antibodies. Antihuman PSGL-I antibody, which does not bind to mouse PSGL-1, had no effect on cell interaction. The importance of PSGL-1 as a P-selectin receptor on 32DC13 cells was shown by blocking 32DC13 cell interaction with CHO-P cells using anti-PSGL-1 antibodies (Fig 7B) . In contrast, the interaction of these cells with CHO-E cells was not affected by the anti-PSGL-I antibodies.
To further characterize the properties of mouse PSGL-I, Northern blot analysis of PSGL-1 mRNA. Total RNAsamples were prepared from 32DC13, PU5-1.8, WEHIJB cells, WW6 embryonic stem cell, and adult mouse tissues. Samples were electrophoresed, transferred, bonded, and hybridized overnight at 65°C using "P-labeled full length cDNA of mouse PSGL-1 as a probe. The blots were finally washed at 70°C with 0 . 5~ SSC/3% SDS for 5 minutes (A) or at 65°C with 2x SSPE/4% SDS for 30 minutes (6, lanes 1 t o 6) and l x SSC/O.2% SDS for 20 minutes (6, lanes 7 t o 12) . The reverse images of the ethidium bromide-stained gels are given underneath. The position of the 28s or the 18s ribosomal RNA is indicated. (A) WEHIJB, 32DC13, PU5-1.8 and WW6 mouse embryonic stem cells; (6) adult mouse tissues as indicated.
the effects of trypsin and neuraminidase on P-selectin binding of WEHI-3B cells were determined. The interaction of WEHI-3B cells with CHO-P cells was completely abolished by treatment of WEHI3B cells with 1 pg/mL of bovine trypsin (Fig 8) . Similarly, treatment of WEHI-3B cells with 200 mU/mL of neuraminidase from V cholerue abolished the ability of these cells to interact with CHO-P cells (Fig  8) . The results showed that the protein backbone and sialic acid are required for mouse PSGL-1 to bind to Pselectin.
For 
DISCUSSION
A number of glycoproteins including PSGL-I and carbohydrates have been identified as counterreceptors or components of counterreceptors for P-seIe~tin.~.'.'"~''.~~~'' Together with the expression cloning of a mucin-like glycoprotein from a cDNA library derived from HL-60 cells." PSGL-I has emerged as an important candidate for the physiological P-selectin receptor. To explore the biology of PSGL-I in vivo using a mouse model, we have cloned and characterized the gene of the mouse homolog of PSGL-I. established a system for expressing the functional receptor in a heterologous expression system, and determined the properties of this protein that are the same and that are distinct from human PSGL-1. The overall sequence of PSGL-1. except in the putative transmembrane domain and the putative cytoplasmic tail, is not highly conserved between human and mouse. The cytoplasmic tail of PSGL-I may play an important role for signal transduction since Celi et al" have shown that binding of P-selectin to monocytes resulted in upregulation of tissue factor gene expression. In addition, Zimmerman's group has reported roles of P-selectin for upregulating the synthesis of monocyte chemotactic factor-I and tumor necrosis factor-a"' and for regulating plateletactivating factor synthesis and phagocytosis by monocytesu.
The repeat regions of mouse and human PSGL-I share the general structural features of mucin-like molecules but are less conserved at the primary sequence level. Variation in the number of repeat units exists in the human PSGL-I For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From gene isolated from HL-60 and U-937 cell lines (15 units) as compared with that of the polymorphonuclear leukocytes, monocytes, and several other cell lines (16 units).37 It is not known whether similar polymorphism exists in different mouse strains. The repeat region may be important for displaying the carbohydrate recognition site for P-selectin. This is consistent with the carbohydrate features carried by the purified PSGL-1 PSGL-1 possesses highly clustered 0-linked sialyl Lewis" tetrasaccharide structures. Although the nature of the N-linked carbohydrate moieties is not known, the human PSGL-1 is N-glyc~sylated.~~.~~ Nlinked carbohydrates on PSGL-1 may also contribute to Pselectin binding, because HL-60 cells treated with the Nglycosylation inhibitor tunicamycin lost binding activity. 39 Despite variations in primary sequence between human PSGL-1 and mouse PSGL-1, COS cells transfected with mouse PSGL-1 cDNA are capable of binding to the human P-selectin-bearing CHO cells. Mouse PSGL-1 -mediated binding to human P-selectin has also been observed with the WEHI-3B and 32DC13 cell lines, and this interaction can be blocked by an anti-PSGL-1 antibody raised against a highly conserved peptide N-terminal of the repeat units of mouse PSGL-1. These results would suggest that the highly conserved residues in this peptide sequence may be important for P-selectin binding. Alternatively, the proximity of the epitope for this antibody to the carbohydrate bearing repeat units may interfere with the binding of the lectin domain of P-selectin to these sugars. The protein backbone of the mouse repeat units, although less conserved between mouse and human, may provide an adequate scaffold for presenting the necessary carbohydrate ligands,
The interaction between endothelial cells or platelets and leukocytes is believed to be controlled by regulated cell surface expression of P-selectin. P-selectin, stored in a granules of platelet^^^,^^ and the Weibel-Palade bodies of endothelial ~ells,"~,~* is redistributed to the cell surface on stimulation with agonists such as thrombin and histamine.49 De novo P-selectin mRNA synthesis can also be induced on endotoxin ti mu la ti on.^' In contrast, PSGL-1 is constitutively expressed on the target cells of P-selectin. In fact, Northern blot analyses showed a major PSGL-1 mRNA species of = 1.8 kb in several mouse myeloid cell lines including PU-5, 32DC13, and WEHI-3B and in hematopoietic tissues including liver, spleen, thymus, and bone marrow. The highest level of PSGL-1 mRNA is present in bone marrow, which is consistent with recent reports that PSGL-1 is expressed in CD34+ hematopoietic pregenitor cell^,^' in myeloid cells, and in all the lymphocyte^.^^^^^ PSGL-1 is also expressed in embryonic stem cells and in all the tissues examined including nonhematopoietic tissues such as brain, adipose tissue, stomach, muscle, and ovary. Interestingly, the expression levels of PSGL-1 in certain nonhematopoietic tissues such as brain and adipose tissue are apparently higher than those in liver and heart. Immunohistochemical staining of mouse tissues also showed PSGL-1 expression in smooth muscle cells of the vessel wall and in connective tissues (M.L. Palomba, personal communication, November 1995). These results suggest additional functions of PSGL-1, perhaps with a spectrum of different posttranslational modifications.
Similar to the human PSGL-1 gene that expresses two transcripts of =2.5 kb and =4 kb, the mouse PSGL-1 gene also transcribes two types of mRNAs, a major species of ~1 . 8 kb and a minor species of 03.4 kb. Recently, Veldman et a13' showed that differential utilization of two polyadenylation sites is involved in regulating the ~2 . 5 -k b and the =4-kb human PSGL-1 transcripts. A different mechanism may be used to regulate the two mouse PSGL-1 transcripts because the 3' untranslated region of PSGL-l contains two adjacent polyadenylation signals that would not be able to account for the differences between the =1.8-kb and the 03.4-kb mRNAs. Furthermore, the 3' untranslated regions of the two species have little homology, and analyses of three independent cDNA clones of mouse PSGL-1 showed an identical sequence at the 3' end. Alternatively, the two transcripts may vary by an infrequent use of a more downstream polyadenylation signal.
PSGL-1 from the mouse and human37 belongs to the class of mucins encoded by a single coding exon. Leukosialin (CD43)53,54 falls into this class. The other classes of mucins are encoded by multiple exons. These include gly~ophorin?~ the carcinoma-associated mucin MUC-1 ?6 and the L-selectin ligands CD3457 and GlyCAM-1 . 58 The mouse PSGL-1 showed distinct binding specificity for P-selectin. WEHI-3B and 32DC13 cells have similar binding affinity to P-selectin. However, 32DC13 cells, from which the ESL-1 l9 was identified, bind markedly better to E-selectin than do WEHI-3B cells. Binding of 32DC13 cells to E-selectin was not affected by an anti-PSGL-1 antibody raised against a peptide derived from mouse PSGL-1. This result suggests that PSGL-1 is a specific ligand for P-selectin but not for E-selectin. This is contrary to a previous report by Asa et al." This group purified PSGL-1 by affinity chromotography using an E-selectin-globulin chimera and showed binding of the purified protein to both E-selectin and P -s e l e~t i n ?~?~~ A monoclonal antibody, PL5, raised against the purified PSGL-1 protein, blocked binding of HL-60 cells or human neutrophils to E-selectin. Their monoclonal antibody may recognize an oligosaccaride antigen carried by PSGL-1. The carbohydrate determinants for Eselectin and P-selectin share overlapping struct~res,8~~~ and the presence of a high concentration of sialyl Lewis" is sufficient to confer E-selectin binding. In our study, the low binding activity of WEHI3B cells for E-selectin may be because of the nature of the oligosaccharides displayed on WEHI-3B cells, carbohydrates that favor P-selectin but not E-selectin recognition. High concentrations of recombinant PSGL-1 or purified PSGL-1 may bind to E-selectin in an interaction that is nonphysiological.2'-2' A distinct function of PSGL-1 was suggested in a T-lymphocyte rolling system using polyclonal antibodies against PSGL-lZ6; PSGL-1 mediated T-lymphocyte rolling on P-selectin but not on E-selectin. Alternatively, PSGL-1 can mediate low-affinity binding to E-selectin, and the recognition site for E-selectin is distinct from that for P-selectin.
In summary, we have cloned the mouse PSGL-1 cDNA to compare the structure of mouse PSGL-1 with that of the human PSGL-1. Although the general domain structure is preserved, mouse PSGL-1 shows only about 50% conservaFor personal use only. on October 22, 2017 . by guest www.bloodjournal.org From tion of the overall amino acid sequence. Although mouse PSGL-1 binds to human P-selectin, the extracellular domain of PSGL-1 that represents the P-selectin receptor shows lower overall sequence similarity. Furthermore, we provide evidence that the mouse myeloid WEHI-3B cell line (which expresses PSGL-1) binds significantly better to P-selectin than to E-selectin. Blocking anti-PSGL-1 antibodies inhibit P-selectin but not E-selectin binding of mouse myeloid 32DC13 cell line. These results provide additional insights into the structure and function of PSGL-1 and will facilitate interpretation of further in vivo studies in the PSGL-1 null mouse. 
